Andrew Quon

Radiologist

Associate Professor of Radiology (Nuclear Medicine) at the Stanford University Medical Center

Imaging Clinic at Stanford Hospital

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6855
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Board Certification: Nuclear Medicine, American Board of Nuclear Medicine (2002)

Residency: UCLA School of Medicine (2002) CA

Internship: Kaiser Foundation Hospital-Oakland (1999) CA

Medical Education: UT Southwestern Medical School (1998) TX

Honors & Awards

Walter Wolf Young Investigator Award, Society of Nuclear Medicine (SNM) (June 2010)

Editor's Choice Best Clinical Manuscript, Journal of Nuclear Medicine (2006)

The Minnies: Scientific Paper of the Year, AuntMinnie (November 2006)

Image of the Year, Society of Nuclear Medicine (June 2005)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence
Ho, A. S., Tsao, G. J., Chen, F. W., Shen, T., Kaplan, M. J., & Yao, M. (2013). Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. CANCER, 119(7), 1349-1356.

Metabolic Tumor Volume Predicts Disease Progression and Survival in Patients with Squamous Cell Carcinoma of the Anal Canal
Bazan, J. G., Koong, A. C., Kapp, D. S., Quon, A., Graves, E. E., & Chang, D. T. (2013). Metabolic Tumor Volume Predicts Disease Progression and Survival in Patients with Squamous Cell Carcinoma of the Anal Canal. JOURNAL OF NUCLEAR MEDICINE, 54(1), 27-32.

Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy.
Abelson, J. A., Murphy, J. D., Trakul, N., Bazan, J. G., Maxim, P. G., & Loo, B. W. (2012). Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. Lung cancer , 78(3), 219-224.

Initial investigation of F-18-NaF PET/CT for identification of vertebral sites amenable to surgical revision after spinal fusion surgery
Quon, A., Dodd, R., Iagaru, A., de Abreu, M. R., Hennemann, S., & Sprinz, C. (2012). Initial investigation of F-18-NaF PET/CT for identification of vertebral sites amenable to surgical revision after spinal fusion surgery. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 39(11), 1737-1744.

Dipeptidyl Peptidase 4 Inhibition Increases Myocardial Glucose Uptake in Nonischemic Cardiomyopathy
Witteles, R. M., Keu, K. V., Quon, A., Tavana, H., & Fowler, M. B. (2012). Dipeptidyl Peptidase 4 Inhibition Increases Myocardial Glucose Uptake in Nonischemic Cardiomyopathy. JOURNAL OF CARDIAC FAILURE, 18(10), 804-809.

Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response and Survival in Patients With Esophageal Cancer
Jayachandran, P., Pai, R. K., Quon, A., Graves, E., Krakow, T. E., & Chang, D. T. (2012). Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response and Survival in Patients With Esophageal Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(2), 471-477.

Comparison of MRI and 18F-NaF PET/CT in patients with patellofemoral pain
Draper, C. E., Quon, A., Fredericson, M., Besier, T. F., Delp, S. L., & Gold, G. E. (2012). Comparison of MRI and 18F-NaF PET/CT in patients with patellofemoral pain. JOURNAL OF MAGNETIC RESONANCE IMAGING, 36(4), 928-932.

Positron Emission Tomography for Predicting Pathologic Response After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Chennupati, S. K., Quon, A., Kamaya, A., Pai, R. K., La, T., & Chang, D. T. (2012). Positron Emission Tomography for Predicting Pathologic Response After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 35(4), 334-339.

Prognostic PET F-18-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer
Nair, V. S., Gevaert, O., Davidzon, G., Napel, S., Graves, E. E., & Plevritis, S. K. (2012). Prognostic PET F-18-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer. CANCER RESEARCH, 72(15), 3725-3734.

Non-Small Cell Lung Cancer: Identifying Prognostic Imaging Biomarkers by Leveraging Public Gene Expression Microarray Data-Methods and Preliminary Results
Gevaert, O., Xu, J., Hoang, C. D., Leung, A. N., Xu, Y., & Plevritis, S. K. (2012). Non-Small Cell Lung Cancer: Identifying Prognostic Imaging Biomarkers by Leveraging Public Gene Expression Microarray Data-Methods and Preliminary Results. RADIOLOGY, 264(2), 387-396.

Patients with patellofemoral pain exhibit elevated bone metabolic activity at the patellofemoral joint
Draper, C. E., Fredericson, M., Gold, G. E., Besier, T. F., Delp, S. L., & Quon, A. (2012). Patients with patellofemoral pain exhibit elevated bone metabolic activity at the patellofemoral joint. JOURNAL OF ORTHOPAEDIC RESEARCH, 30(2), 209-213.

Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non-Small-Cell Lung Cancer
Lee, P., Bazan, J. G., Lavori, P. W., Weerasuriya, D. K., Quon, A., & Loo, B. W. (2012). Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non-Small-Cell Lung Cancer. CLINICAL LUNG CANCER, 13(1), 52-58.

Pattern of 18F-FDG Uptake in the Spinal Cord in Patients With Non-Central Nervous System Malignancy
Do, B. H., Mari, C., Tseng, J. R., Quon, A., Rosenberg, J., & Biswal, S. (2011). Pattern of 18F-FDG Uptake in the Spinal Cord in Patients With Non-Central Nervous System Malignancy. SPINE, 36(21), E1395-E1401.

POSTRADIATION METABOLIC TUMOR VOLUME PREDICTS OUTCOME IN HEAD-AND-NECK CANCER
Murphy, J. D., La, T. H., Chu, K., Quon, A., Fischbein, N. J., & Le, Q.-T. (2011). POSTRADIATION METABOLIC TUMOR VOLUME PREDICTS OUTCOME IN HEAD-AND-NECK CANCER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 80(2), 514-521.

Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer
Kozak, M. M., Murphy, J. D., Schipper, M. L., Donington, J. S., Zhou, L., & Loo, B. W. (2011). Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 6(5), 920-926.

F-18-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases
Zissen, M. H., Kunz, P., Subbarayan, M., Chin, F. T., Conti, P. S., & Quon, A. (2011). F-18-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases. NUCLEAR MEDICINE COMMUNICATIONS, 32(5), 343-347.

Rosiglitazone Increases Myocardial Glucose Metabolism in Insulin-Resistant Cardiomyopathy
Kao, D. P., Witteles, R. M., Quon, A., Wu, J. C., Gambhir, S. S., & Fowler, M. B. (2010). Rosiglitazone Increases Myocardial Glucose Metabolism in Insulin-Resistant Cardiomyopathy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 55(9), 926-927.

Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study
Horning, S. J., Juweid, M. E., Schoeder, H., Wiseman, G., McMillan, A., & Quon, A. (2010). Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study. BLOOD, 115(4), 775-777.

Efficacy of F-18-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma
Mittra, E., El-Maghraby, T., Rodriguez, C. A., Quon, A., McDougall, I. R., & Iagaru, A. (2009). Efficacy of F-18-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 36(12), 1952-1959.

Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging
Zissen, M. H., & Quon, A. (2009). Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 36(9), 1527-1527.

METABOLIC TUMOR VOLUME PREDICTS FOR RECURRENCE AND DEATH IN HEAD-AND-NECK CANCER
La, T. H., Filion, E. J., Turnbull, B. B., Chu, J. N., Lee, P., & Le, Q.-T. (2009). METABOLIC TUMOR VOLUME PREDICTS FOR RECURRENCE AND DEATH IN HEAD-AND-NECK CANCER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 74(5), 1335-1341.

Simulations of Virtual PET/CT 3-D Bronchoscopy Imaging Using a Physical Porcine Lung-Heart Phantom
Yerushalmi, D., Mullick, R., Quon, A., Fahrig, R., Pelc, N. J., & Gambhir, S. S. (2009). Simulations of Virtual PET/CT 3-D Bronchoscopy Imaging Using a Physical Porcine Lung-Heart Phantom. MOLECULAR IMAGING AND BIOLOGY, 11(4), 275-282.

Detection of Solitary Humeral Metastasis From Pancreatic Adenocarcinoma With F-18 FDG PET/CT
Kim, J., Quon, A., Humke, E., Ford, J. M., & Koong, A. C. (2009). Detection of Solitary Humeral Metastasis From Pancreatic Adenocarcinoma With F-18 FDG PET/CT. CLINICAL NUCLEAR MEDICINE, 34(5), 312-313.

Novel Strategy for a Cocktail F-18-Fluoride and F-18-FDG PET/CT Scan for Evaluation of Malignancy: Results of the Pilot-Phase Study
Iagaru, A., Mittra, E., Yaghoubi, S. S., Dick, D. W., Quon, A., & Gambhir, S. S. (2009). Novel Strategy for a Cocktail F-18-Fluoride and F-18-FDG PET/CT Scan for Evaluation of Malignancy: Results of the Pilot-Phase Study. JOURNAL OF NUCLEAR MEDICINE, 50(4), 501-505.

Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas
Chang, D. T., Schellenberg, D., Shen, J., Kim, J., Goodman, K. A., & Koong, A. C. (2009). Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas. CANCER, 115(3), 665-672.

Positron Emission Tomography/Computed Tomography: The Current Technology and Applications
Mittra, E., & Quon, A. (2009). Positron Emission Tomography/Computed Tomography: The Current Technology and Applications. RADIOLOGIC CLINICS OF NORTH AMERICA, 47(1), 147-?.

PET/CT Imaging of Gastrointestinal Stromal Tumor With Calcified Peritoneal Implants After Imatinib Therapy
Eslamy, H. K., & Quon, A. (2008). PET/CT Imaging of Gastrointestinal Stromal Tumor With Calcified Peritoneal Implants After Imatinib Therapy. CLINICAL NUCLEAR MEDICINE, 33(12), 864-865.

F-18-FDG PET/CT evaluation of patients with ovarian carcinoma
Iagaru, A. H., Mittra, E. S., McDougall, I. R., Quon, A., & Gambhir, S. S. (2008). F-18-FDG PET/CT evaluation of patients with ovarian carcinoma. NUCLEAR MEDICINE COMMUNICATIONS, 29(12), 1046-1051.

Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer
Schellenberg, D., Goodman, K. A., Lee, F., Chang, S., Kuo, T., & Koong, A. C. (2008). Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 72(3), 678-686.

F-18-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?
Iagaru, A., Wang, Y., Mari, C., Quon, A., Goris, M. L., & Gambhir, S. S. (2008). F-18-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 11(3), 153-156.

Initial evaluation of F-18-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer
Quon, A., Chang, S. T., Chin, F., Kamaya, A., Dick, D. W., & Koong, A. C. (2008). Initial evaluation of F-18-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 35(3), 527-531.

I-123 MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma
Iagaru, A., Peterson, D., Quon, A., Dutta, S., Twist, C., & Albanese, C. (2008). I-123 MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma. MOLECULAR IMAGING AND BIOLOGY, 10(1), 19-23.

FDG PET/CT detection of a gossypiboma in the neck
Niederkohr, R. D., Hwang, B. J., & Quon, A. (2007). FDG PET/CT detection of a gossypiboma in the neck. CLINICAL NUCLEAR MEDICINE, 32(11), 893-895.

Molecular imaging techniques in body imaging
Margolis, D. Ja., Hoffman, J. M., Herfkens, R. J., Jeffrey, R. B., Quon, A., & Gambhir, S. S. (2007). Molecular imaging techniques in body imaging. RADIOLOGY, 245(2), 333-356.

Metabolic tumor burden predicts for disease progression and death in lung cancer
Lee, P., Weerasuriya, D. K., Lavori, P. W., Quon, A., Hara, W., & Loo, B. W. (2007). Metabolic tumor burden predicts for disease progression and death in lung cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 69(2), 328-333.

Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease
Advani, R., Maeda, L., Lavori, P., Quon, A., Hoppe, R., & Horning, S. J. (2007). Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 25(25), 3902-3907.

Clinical value of including the head and lower extremities in F-18-FDG PET/CT imaging for patients with malignant melanoma
Niederkohr, R. D., Rosenberg, J., Shabo, G., & Quon, A. (2007). Clinical value of including the head and lower extremities in F-18-FDG PET/CT imaging for patients with malignant melanoma. NUCLEAR MEDICINE COMMUNICATIONS, 28(9), 688-695.

No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine
Niederkohr, R. D., & Quon, A. (2007). No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine. CLINICAL NUCLEAR MEDICINE, 32(4), 302-303.

Advances in metabolic imaging for surgical oncology
Iagaru, A., & Quon, A. (2007). Advances in metabolic imaging for surgical oncology. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 16(2), 273-?.

RT_Image: An open-source tool for investigating PET in radiation oncology
Graves, E. E., Quon, A., & Loo, B. W. (2007). RT_Image: An open-source tool for investigating PET in radiation oncology. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 6(2), 111-121.

Detection of bone metastases: Assessment of integrated FDG PET/CT imaging
Taira, A. V., Herfkens, R. J., Gambhir, S. S., & Quon, A. (2007). Detection of bone metastases: Assessment of integrated FDG PET/CT imaging. RADIOLOGY, 243(1), 204-211.

Impact of integrated PET/CT on variability of target volume delineation in rectal cancer
Patel, D. A., Chang, S. T., Goodman, K. A., Quon, A., Thorndyke, B., & Koong, A. C. (2007). Impact of integrated PET/CT on variability of target volume delineation in rectal cancer. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 6(1), 31-36.

2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma
Iagaru, A., Quon, A., Johnson, D., Gambhir, S. S., & McDougall, I. R. (2007). 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma. MOLECULAR IMAGING AND BIOLOGY, 9(1), 50-57.

Clinical role of F-18-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma
Quon, A., Fischbein, N. J., McDougall, I. R., Le, Q.-T., Loo, B. W., & Kaplan, M. J. (2007). Clinical role of F-18-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. JOURNAL OF NUCLEAR MEDICINE, 48, 58S-67S.

F-18FDG PET/CT evaluation of osseous and soft tissue sarcomas
Iagaru, A., Quon, A., McDougall, T. R., & Gambhir, S. S. (2006). F-18FDG PET/CT evaluation of osseous and soft tissue sarcomas. CLINICAL NUCLEAR MEDICINE, 31(12), 754-760.

Sonography of the abnormal parathyroid gland.
Kamaya, A., Quon, A., & Jeffrey, R. B. (2006). Sonography of the abnormal parathyroid gland. Ultrasound quarterly, 22(4), 253-262.

F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp
Vasanawala, M. S., Wang, Y., Quon, A., & Gambhir, S. S. (2006). F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp. CLINICAL NUCLEAR MEDICINE, 31(9), 534-537.

"Flying through" and "flying around" a PET/CT scan: Pilot study and development of 3D integrated F-18-FDG PET/CT for virtual bronchoscopy and colonoscopy
Quon, A., Napel, S., Beaulieu, C. F., & Gambhir, S. S. (2006). "Flying through" and "flying around" a PET/CT scan: Pilot study and development of 3D integrated F-18-FDG PET/CT for virtual bronchoscopy and colonoscopy. JOURNAL OF NUCLEAR MEDICINE, 47(7), 1081-1087.

Merkel cell carcinoma: Is there a role for 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography?
Iagaru, A., Quon, A., McDougall, I. R., & Gambhir, S. S. (2006). Merkel cell carcinoma: Is there a role for 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography?. MOLECULAR IMAGING AND BIOLOGY, 8(4), 212-217.

Staging accuracy in mycosis fungoides and Sezary syndrome using integrated positron emission tomography and computed tomography
Tsai, E. Y., Taur, A., Espinosa, L., Quon, A., Johnson, D., & Kim, Y. H. (2006). Staging accuracy in mycosis fungoides and Sezary syndrome using integrated positron emission tomography and computed tomography. ARCHIVES OF DERMATOLOGY, 142(5), 577-584.

Diagnosis of aseptic deep venous thrombosis of the upper extremity in a cancer patient using fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT)
Do, B., Mari, C., Biswal, S., Kalinyak, J., Quon, A., & Gambhir, S. S. (2006). Diagnosis of aseptic deep venous thrombosis of the upper extremity in a cancer patient using fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT). ANNALS OF NUCLEAR MEDICINE, 20(2), 151-155.

Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients
Fueger, B. J., Weber, W. A., Quon, A., Crawford, T. L., Allen-Auerbach, M. S., & Czernin, J. (2005). Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients. MOLECULAR IMAGING AND BIOLOGY, 7(5), 369-376.

FDG-PET and beyond: Molecular breast cancer imaging
Quon, A., & Gambhir, S. S. (2005). FDG-PET and beyond: Molecular breast cancer imaging. JOURNAL OF CLINICAL ONCOLOGY, 23(8), 1664-1673.

Comparison between 2-deoxy-2-[F-18]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma
Allen-Auerbach, M., Quon, A., Weber, W. A., Obrzut, S., Crawford, T., & Czernin, J. (2004). Comparison between 2-deoxy-2-[F-18]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. MOLECULAR IMAGING AND BIOLOGY, 6(6), 411-416.

Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability
Halpern, B. S., Dahlbom, M., Quon, A., Schiepers, C., Waldherr, C., & Czernin, J. (2004). Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. JOURNAL OF NUCLEAR MEDICINE, 45(5), 797-801.

Conventional imaging and 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease
Filmont, J. E., Yap, C. S., Ko, F., Vranjesevic, D., Quon, A., & Czernin, J. (2004). Conventional imaging and 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease. MOLECULAR IMAGING AND BIOLOGY, 6(1), 47-54.

Relationship between F-18-FDG uptake and breast density in women with normal breast tissue
Vranjesevic, D., Schiepers, C., Silverman, D. H., Quon, A., Villalpando, J., & Czernin, J. (2003). Relationship between F-18-FDG uptake and breast density in women with normal breast tissue. JOURNAL OF NUCLEAR MEDICINE, 44(8), 1238-1242.

Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation
Filmont, J. E., Czernin, J., Yap, C., Silverman, D. Hs., Quon, A., & Emmanouilides, C. (2003). Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation. CHEST, 124(2), 608-613.

Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients.
Filmont, J.-E., Vranjesevic, D., Quon, A., Margolis, D. Ja., Ko, F., & Czernin, J. (2003). Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients. Molecular imaging and biology , 5(4), 232-239.